美股市場個股詳情
ASPN Aspen Aerogels
- 26.710
- +0.080+0.30%
收盤價 05/09 16:00 (美東)
- 27.268
- +0.558+2.09%
盤後 16:33 (美東)
20.34億總市值-60704市盈率TTM
27.190最高價26.240最低價100.63萬股成交量26.680今開26.630昨收2692.59萬成交額1.34%換手率虧損市盈率(靜)7616.12萬總股本27.19052周最高4.14市淨率20.06億流通值5.32552周最低--股息TTM7509.74萬流通股65.986歷史最高--股息率TTM3.57%振幅1.600歷史最低26.756平均價1股每手
Aspen Aerogels股票討論區
登錄發表評論
$Aspen Aerogels(ASPN.US$ let's gp
2
Aspen Aerogels' high P/S ratio is backed by strong revenue growth, outpacing the Chemicals industry. Investors' confidence in future revenues supports the high P/S ratio and share price. Yet, the company's prospects shouldn't be judged solely on the P/S ratio.
Aspen Aerogel's high P/S ratio is echoed by strong revenue growth, surpassing industry standard. With impressive growth forecasts exceeding industry estimates, the high P/S ratio is justifiable. The stock's rising trend indicates shareholders foresee continued outperformance, with no sharp drop in share price anticipated soon.
Aspen Aerogels has drawn concerns due to its liabilities and absence of EBIT level profitability despite observing 41% revenue growth. Given the debt usage, its current state appears risky, necessitating close monitoring of balance sheet and understanding the high risks tied to the stock.
Gainers:
• $Exicure(XCUR.US$ stock is rocketing more than 2,313% due to a one-for-30 reverse stock split.
• $Revelation Biosciences(REVB.US$ shares are soaring over 120% alongside heavy trading this morning.
• $Remark Holdings(MARK.US$ stock is surging more than 55% with heavier-than-normal trading this morning.
• $374Water(SCWO.US$ shares are gaining over 54% ahead of its Nasdaq bell ringing tomorrow.
• $Aspen Aerogels(ASPN.US$ ...
• $Exicure(XCUR.US$ stock is rocketing more than 2,313% due to a one-for-30 reverse stock split.
• $Revelation Biosciences(REVB.US$ shares are soaring over 120% alongside heavy trading this morning.
• $Remark Holdings(MARK.US$ stock is surging more than 55% with heavier-than-normal trading this morning.
• $374Water(SCWO.US$ shares are gaining over 54% ahead of its Nasdaq bell ringing tomorrow.
• $Aspen Aerogels(ASPN.US$ ...
17
Gainers:
• $Intercept Pharmaceuticals(ICPT.US$ +25.7% (to sell license to commercialize Ocaliva outside the US to Advanz Pharma for upfront payment of $405 mln)
• $美國雅保(ALB.US$ +13.9% (earnings reports)
• $Booking Holdings(BKNG.US$ +10% (Booking Holdings' Outlook for a 'Busy' summer season drives the stock sharply higher)
• $AxoGen(AXGN.US$ +9% (reports top-line results from RECON study of Avance Nerge Graft)
• $積雲媒體(CMLS.US$ +7.2% (an...
• $Intercept Pharmaceuticals(ICPT.US$ +25.7% (to sell license to commercialize Ocaliva outside the US to Advanz Pharma for upfront payment of $405 mln)
• $美國雅保(ALB.US$ +13.9% (earnings reports)
• $Booking Holdings(BKNG.US$ +10% (Booking Holdings' Outlook for a 'Busy' summer season drives the stock sharply higher)
• $AxoGen(AXGN.US$ +9% (reports top-line results from RECON study of Avance Nerge Graft)
• $積雲媒體(CMLS.US$ +7.2% (an...
15
1
Gainers
In reaction to earnings/guidance:
$PagerDuty(PD.US$ +13.6%, $西格內特珠寶(SIG.US$ +8.5%, $奮進集團(EDR.US$ +7.4%, $Williams-Sonoma(WSM.US$ +7.3%(also announces 10% dividend increase; $1.5 bln share buyback authorization), $Braskem(BAK.US$ +7%, $埃森哲(ACN.US$ +5.1%
Other news:
- $Eneti(NETI.US$ +7.5% (signs new contract for wind turbine operation and maintenance)
- $螺旋能源(HLX.US$ +3.8% (receives con...
In reaction to earnings/guidance:
$PagerDuty(PD.US$ +13.6%, $西格內特珠寶(SIG.US$ +8.5%, $奮進集團(EDR.US$ +7.4%, $Williams-Sonoma(WSM.US$ +7.3%(also announces 10% dividend increase; $1.5 bln share buyback authorization), $Braskem(BAK.US$ +7%, $埃森哲(ACN.US$ +5.1%
Other news:
- $Eneti(NETI.US$ +7.5% (signs new contract for wind turbine operation and maintenance)
- $螺旋能源(HLX.US$ +3.8% (receives con...
20
2
Totally would advise against it, but if I had to it would be one of these:
RKLB $Rocket Lab(RKLB.US$
NVDA $英偉達(NVDA.US$
ASPN $Aspen Aerogels(ASPN.US$
RKLB $Rocket Lab(RKLB.US$
NVDA $英偉達(NVDA.US$
ASPN $Aspen Aerogels(ASPN.US$
5
2
$Aspen Aerogels(ASPN.US$ ASPN - Aspeb Aerogel. Like 98% owned by institutions and insiders. Explosive growth this year. They are primed to exploded with the EV sector since they are making thermal barriers on batteries. Also is a play on the grid updates and green buildings. They are opening a second factory soon.
$Rocket Lab(RKLB.US$ RKLB - Rocketlab. They hands down have the moat for small satellite launches. I think the most profitable sector will be the small satellite industry. Boeing and others already announced they want to launch their own small constellations.
Rocketlab also owns their own launch space, which means they can custom tailor launches for companies. They just successfully launched two satellites for black sky. Also, their rockets are reusable.
They have some announcement coming up on the 2nd talking about their bigger rocket, neutron. It’s should be ready by 2024. It’s reusable and the closest thing to Falcon 9 from SpaceX.
$Rocket Lab(RKLB.US$ RKLB - Rocketlab. They hands down have the moat for small satellite launches. I think the most profitable sector will be the small satellite industry. Boeing and others already announced they want to launch their own small constellations.
Rocketlab also owns their own launch space, which means they can custom tailor launches for companies. They just successfully launched two satellites for black sky. Also, their rockets are reusable.
They have some announcement coming up on the 2nd talking about their bigger rocket, neutron. It’s should be ready by 2024. It’s reusable and the closest thing to Falcon 9 from SpaceX.
5
暫無評論
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅
102494559 : 衝不破壓力位
Tom2808樓主 102494559: 慢慢衝。可以的